GFAP and diabetic retinopathy: Hanaguri et al. reported that TBE plus lutein improved retinal blood flow, prevented glial fibrillary acidic protein activation, decreased VEGF expression in the retina, and prevented neovascularization, concluding that TBE plus lutein may prevent diabetic retinopathy [22].